VENTUROLI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 3.162
AS - Asia 3.094
EU - Europa 2.408
AF - Africa 194
SA - Sud America 131
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 8.994
Nazione #
US - Stati Uniti d'America 3.120
CN - Cina 888
VN - Vietnam 875
SG - Singapore 749
GB - Regno Unito 605
IT - Italia 392
DE - Germania 317
SE - Svezia 252
UA - Ucraina 228
HK - Hong Kong 179
FR - Francia 168
IN - India 154
RU - Federazione Russa 135
IE - Irlanda 79
BR - Brasile 76
JP - Giappone 58
ZA - Sudafrica 54
CI - Costa d'Avorio 53
NL - Olanda 51
KR - Corea 42
EE - Estonia 40
TG - Togo 40
FI - Finlandia 39
BG - Bulgaria 32
CA - Canada 28
SC - Seychelles 22
BD - Bangladesh 20
AR - Argentina 19
NG - Nigeria 18
IR - Iran 16
BE - Belgio 14
JO - Giordania 14
PH - Filippine 14
TH - Thailandia 14
CH - Svizzera 12
AT - Austria 10
ID - Indonesia 10
TW - Taiwan 10
TR - Turchia 9
UZ - Uzbekistan 9
MX - Messico 8
IQ - Iraq 7
CL - Cile 6
CO - Colombia 6
LT - Lituania 6
SA - Arabia Saudita 6
EC - Ecuador 5
GR - Grecia 5
PE - Perù 5
PK - Pakistan 5
PY - Paraguay 5
UY - Uruguay 5
ES - Italia 4
HN - Honduras 4
LB - Libano 4
PL - Polonia 4
RO - Romania 4
EU - Europa 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HR - Croazia 2
KE - Kenya 2
MY - Malesia 2
PT - Portogallo 2
TN - Tunisia 2
VE - Venezuela 2
AZ - Azerbaigian 1
CY - Cipro 1
ET - Etiopia 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
VI - Stati Uniti Isole Vergini 1
Totale 8.994
Città #
Southend 523
Singapore 495
Ashburn 318
Dong Ket 301
Chandler 269
San Jose 200
Fairfield 196
Hong Kong 166
Jacksonville 151
Ho Chi Minh City 145
Hanoi 129
Wilmington 120
Princeton 113
Houston 112
Woodbridge 107
Ann Arbor 105
Beijing 104
Hefei 104
Seattle 101
Santa Clara 97
Boardman 92
Dublin 79
Cambridge 73
Padova 54
Westminster 54
Abidjan 53
Lauterbourg 53
Tokyo 53
Nanjing 52
Los Angeles 51
Milan 49
Council Bluffs 48
Dallas 45
Lomé 40
New York 40
Bologna 39
Berlin 38
Buffalo 36
Medford 35
Redwood City 34
Sofia 32
Helsinki 31
Seoul 31
Jinan 29
Changsha 25
Da Nang 25
Saint Petersburg 25
Shenyang 25
Mülheim 24
Shanghai 23
Hebei 22
Guangzhou 21
Rome 21
Nanchang 20
Tianjin 20
Florence 19
Haiphong 19
Abeokuta 17
Bremen 17
Hangzhou 17
Mahé 17
Frankfurt am Main 16
Zhengzhou 16
Amman 14
Brussels 14
Dearborn 13
Munich 13
Des Moines 12
Olalla 12
San Diego 12
Bengaluru 11
Bern 11
Haikou 10
Phoenix 10
Redondo Beach 10
Biên Hòa 9
Brooklyn 9
Orem 9
Paris 9
Falkenstein 8
Kunming 8
São Paulo 8
Taiyuan 8
Taizhou 8
Toronto 8
Jiaxing 7
Montreal 7
Shenzhen 7
Shijiazhuang 7
Turin 7
Vienna 7
Ardabil 6
Bolzano 6
Kuban 6
Naples 6
Ningbo 6
Pune 6
Quận Bình Thạnh 6
San Francisco 6
San Venanzo 6
Totale 5.708
Nome #
Comparison of HPV sign Genotyping Test with INNO-LiPA HPV Genotyping Extra assay on histologic and cytologic cervical specimens 331
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 218
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 203
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 199
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 193
A loop mediated isothermal amplification (LAMP) assay to detect viral DNA in clinical specimens: BK polyomavirus and parvovirus B19 191
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 190
Analysis of HPV16 E6*I-II transcripts in cervical samples 190
Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012–2024: COVID‐19 Pre‐Pandemic, Pandemic and Post‐Pandemic Trends 184
Analisi della competenza funzionale di cloni genomici di parvovirus B19 181
Presence of cutaneous human papillomavirus DNA in squamous cell carcinoma of the scalp: a case series. 181
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 180
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 177
High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method. 177
Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas 176
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 174
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 170
Detection of high-risk Human Papilloma Virus type 16 and 18 using Isothermal Helicase-Dependent Amplification 168
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 166
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 166
Analysis of the functional competence of genomic clones of Parvovirus B19 162
Virologic and genetic evaluation of vemurafenib-induced skin cancers 162
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 161
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 160
Lo studio PATER: Population-Based Frequency Assessment of HPV Infections in Borderline Pap Tests in the Emilia-Romagna Region 159
Human papillomavirus evaluation of vemurafenib induced skin epithelial tumors: a case series 159
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 158
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 154
Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay 153
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 151
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 150
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 148
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 148
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study. 148
Sviluppo di un saggio di spettrometria di massa, ad elevata processività, per la ricerca e genotipizzazione di 12 HPV ad alto rischio oncogeno 148
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la colocalizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 143
Human papillomavirus type 16 detected in four periungual squamous cell carcinomas from the same patient. 143
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 142
Chlamydia trachomatis and Neisseria gonorrhoeae rectal infections: Interplay between rectal microbiome, HPV infection and Torquetenovirus 142
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 141
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 141
Implicazioni nella progressione della patologia cervicale 140
The detection of human papillomavirus-16 in squamous cell carcinoma of the nail unit: A case series 140
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 131
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 129
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 129
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 127
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 125
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 124
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 121
Detection of parvovirus B19 IgG: choice of antigens and serological tests 121
Quantitative immunohistochemistry and in situ hybridisation imaging procedures with luminescence detection: a new potential diagnostic tool 117
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 112
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 109
Primary and secondary prevention of human papillomavirus-associated cancer: it's not all about women 105
Ultrasensitive bioanalytical imaging 104
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 97
Humoral immune response to parvovirus B19 and serological diagnosis of B19 infection 59
Molecular Testing in Organ Biopsies and Perfusion Fluid Samples from Severe Acute Respiratory Syndrome Coronavirus 2 Positive Donors 56
B19 virus genome diversity: Epidemiological and clinical correlations 43
Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases 33
Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: Concordance and correlation with cytological results 30
Evaluation of commercial kits for the detection and typing of human papillomavirus in cervical swabs 28
Totale 9.168
Categoria #
all - tutte 23.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021367 0 0 0 0 0 0 0 0 0 0 0 367
2021/20221.001 72 67 46 82 88 61 15 55 42 118 170 185
2022/20231.103 106 171 52 158 88 63 31 75 177 26 103 53
2023/2024403 24 49 23 60 31 79 53 27 6 11 19 21
2024/20251.221 60 214 105 80 185 63 100 39 19 72 56 228
2025/20262.699 238 277 274 229 307 152 208 54 546 226 119 69
Totale 9.168